Abstract

Chronic neuroinflammation is an integral pathological feature of major neurodegenerative diseases. The recruitment of microglia to affected brain regions and the activation of these cells are the major events leading to disease-associated neuroinflammation. In a previous study, we showed that neuron-released α-synuclein can activate microglia through activating the Toll-like receptor 2 (TLR2) pathway, resulting in proinflammatory responses. However, it is not clear whether other signaling pathways are involved in the migration and activation of microglia in response to neuron-released α-synuclein. In the current study, we demonstrated that TLR2 activation is not sufficient for all of the changes manifested by microglia in response to neuron-released α-synuclein. Specifically, the migration of and morphological changes in microglia, triggered by neuron-released α-synuclein, did not require the activation of TLR2, whereas increased proliferation and production of cytokines were strictly under the control of TLR2. Construction of a hypothetical signaling network using computational tools and experimental validation with various peptide inhibitors showed that β1-integrin was necessary for both the morphological changes and the migration. However, neither proliferation nor cytokine production by microglia was dependent on the activation of β1-integrin. These results suggest that β1-integrin signaling is specifically responsible for the recruitment of microglia to the disease-affected brain regions, where neurons most likely release relatively high levels of α-synuclein.

Highlights

  • IntroductionParkinson’s disease (PD) is characterized by the loss of dopamine neurons in the substantia nigra pars compacta and is associated with abnormal protein accumulation in forms known as Lewy bodies (LBs) and Lewy neurites.[2] LBs and

  • Parkinson’s disease (PD) is an age-related neurodegenerative disease characterized by motor and non-motor symptoms.[1]Pathologically, PD is characterized by the loss of dopamine neurons in the substantia nigra pars compacta and is associated with abnormal protein accumulation in forms known as Lewy bodies (LBs) and Lewy neurites.[2]

  • Toll-like receptor 2 (TLR2)-dependent and -independent microglial responses to neuron-released a-synuclein Our previous study demonstrated a role for TLR2 in at least some aspects of neuron-released a-synuclein-induced microglial activation

Read more

Summary

Introduction

PD is characterized by the loss of dopamine neurons in the substantia nigra pars compacta and is associated with abnormal protein accumulation in forms known as Lewy bodies (LBs) and Lewy neurites.[2] LBs and. A-synuclein is a typical neuronal cytosolic protein, some a-synuclein is released from neurons[6] and is present in body fluids such as the cerebrospinal fluid, serum and brain interstitial fluid.[7,8] Extracellular a-synuclein is transferred to neighboring neurons and astrocytes, promoting abnormal accumulation of a-synuclein, which induces cell death in the neurons[9,10] and an inflammatory response in the astrocytes.[11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call